¿Aspirina en prevención primaria? Recalculando: no se demostró beneficio en un estudio que incluyó a casi 20 mil adultos mayores sanos. https://t.co/i2MkXtTf7w @NEJM
A recent study published in the @NEJM indicates that taking an Aspirin a day has NO health benefits for health seniors over the age of 70. Read the full study https://t.co/BC0kWLjNJu #nejm #aspirin #tolkwellnesscenter https://t.co/TfbvqCq15i
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/YBIvvjnjRG
Interesting finding #Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo. #ageing #cardiovascular https://t.co/AoNKpjWOtw
RT @JLBrown_UIowa: Michael Ernst @UIPharmacy @IowaMed is part of the #ASPREE study that finds low-dose aspirin may do more harm than good i…
RT @MichaelSagnerMD: Absolutely essential findings for #preventivemedicine Is Aspirin a preventive agent? at what dosage? what side effects…
RT @erlesen: Primary prevention with 100mg Aspirin does not decrease cardiovascular disease but rather promotes hemorrhage https://t.co/Ceu…
RT @erlesen: Primary prevention with 100mg Aspirin does not decrease cardiovascular disease but rather promotes hemorrhage https://t.co/Ceu…
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
Study finds the rate of death and physical disability was 21.5 events pr 1000 py in the group taking daily aspirin and 21.2 pr 1000 py placebo group. Hence there are no significant benefits of daily aspirin intake by healthy elders. @BasiaDiug #sphpm https
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. https://t.co/OVRxWGQyZw
¿Y los objetivos principales del estudio ASPREE llegaron a cumplirse? Otro fracaso: la aspirina (100 mg/dìa) no sólo no aumentó la esperanza de vida en buena salud de ancianos sanos,sino que aumentó la incidencia de hemorragias graves, versus placebo.https
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. https://t.co/mD4ZfZJoN7
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @AgingBiology: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/H8jDEmw9zK
RT @carvicab: Un hilo de Topol comentando resultados del ASPREE. No es de utilidad tomar aspirina a bajas dosis si se es un anciano sano.…
RT @carvicab: El estudio incluyó más de 19 mil personas y está publicado en el New England Medical Journal , una de las revistas médicas má…
RT @thenephrologist: Should we stop aspirin same time as #statin? #StopPolypharmacy https://t.co/XNU27rE5Nv
RT @womensbrainpro: Important read. Aspirin does not improve health aging in non at risk patients! https://t.co/ayxsXuvHxi
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
Aspirin 100mg/d in >65yo’s same survival in 5y but more hemorrhage than placebo. https://t.co/wsa07XJbqh
RT @JLBrown_UIowa: Michael Ernst @UIPharmacy @IowaMed is part of the #ASPREE study that finds low-dose aspirin may do more harm than good i…
Effect of aspirin on disability-free survival in the healthy elderly https://t.co/ayLrQkRP6Y https://t.co/hHWwmppOK4
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @MaanFares: #Aspirin not advised in healthy subjects beyond 70. Case by case strategy is best https://t.co/BSkZHsTvyz
RT @redGDPS: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/EEMFodudBR Aspirin use in healthy elderly p…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @Drroxmehran: No benefit for ASA in healthy elderly ASPREE investigators https://t.co/YIhJpq5fbT
The results of the study, led by John McNeil of Monash University in Melbourne, were released Sunday in three articles in the New England Journal of Medicine. The Aspirin in Reducing Events in the Elderly (ASPREE) paper is here: https://t.co/Z2WKFeqmgj
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @VivekSubbiah: Glad we did not add aspirin to the city water supply based on previous studies 👉 Sunday 🤔 what do you say @Aiims1742 @nee…
I've predicted for years that someday doctors will tell us that bacon is good for us. It's coming. Wait for it.
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @syuichiao89: こちらがメイン論文ですね。 https://t.co/oKFdaepClZ 見事に差がねぇ。
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
こちらがメイン論文ですね。 https://t.co/oKFdaepClZ 見事に差がねぇ。
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
AT2B: Challenge 4 The journal article behind the ASPREE trials stating that "differences between the aspirin group and the placebo group were not substantial". Amazing to see Monash Uni involved in such a big clinical trial! @BasiaDiug @PennyRobaus #Sphpm
Some amazing research to back up that previous @theage article! https://t.co/hhjwvuOpup @BasiaDiug @PennyRobaus #Sphpm
RT @silex_transl: 「毎日の低用量 #アスピリン で延命」単純明快なASPREE試験が失敗。出血だけでなく癌死も多かった。MonashのMcNeil :「有益部分群もありません。ただし、癌リスクには留保をつけます」。 https://t.co/CqE1l9Na…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @AnastasiaSMihai: Congratulations @profcmreid, Dr Robyn Woods 🇦🇺& coauthors & due recognition in @NEJM 👏👏 Effect of Aspirin on Disabili…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @HansaBhargavaMD: Low dose aspirin for elders? Not a good idea! @EricTopol @Medscape @DrRobertGlatter https://t.co/10BpsQM9yl
RT @DrDrugExpert: An Aspirin a day does NOT keep the doctor away in healthy elderly. Actually the risks of aspirin related bleeding and sid…
RT @DrDrugExpert: An Aspirin a day does NOT keep the doctor away in healthy elderly. Actually the risks of aspirin related bleeding and sid…
These studies are for otherwise healthy seniors. Where to draw the line for risk vs. benefit ?What r stats for elderly with CVD? Is there a benefit if CVD is present that is significant or should no one regardless of CVD be given aspirin in primary prevent
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/Q3qlAeMHDD
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
when I deprescribe prim prev ASA in the elderly, I always get that "doc, why do you want me to die?" kind of look...
RT @nicolasrennamd: 3 ° gol en contra para la aspirina en la prevención primaria? Primero ARRIVE con 12546p de riesgo moderado, ASCEND con…
今までの常識は覆るのか?
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
The NEW ENGLAND JOURNAL of MEDICINE: Use of aspirin as a primary prevention for cardiovascular disease brings NO benefits. Date published: 16th Sept https://t.co/TA1UuxU2Dq https://t.co/POlLmv48MT https://t.co/Hs9mhDKVFz
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @DrKentMeredith: Yes, but it will be important that media outlets don’t mislead the public while reporting these results. This does not…
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @DrDrugExpert: An Aspirin a day does NOT keep the doctor away in healthy elderly. Actually the risks of aspirin related bleeding and sid…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @quequesierra: (NEJM) Effect of Aspirin on Disability-free Survival in the Healthy Elderly 🛑La aspirina en pacientes “mayores” no parec…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @juliomcrosa: EFECTO DE LA ASPIRINA EN LA SUPERVIVENCIA LIBRE DE DISCAPACIDAD EN ANCIANOS SANOS (¿Cae un mito?) https://t.co/kGh0nJEpLT
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
Effect of #Aspirin on #Disability-free #Survival in the Healthy #Elderly https://t.co/fQL0bcovFo @NEJM #ECM
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @juliomcrosa: EFECTO DE LA ASPIRINA EN LA SUPERVIVENCIA LIBRE DE DISCAPACIDAD EN ANCIANOS SANOS (¿Cae un mito?) https://t.co/kGh0nJEpLT
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Here we go again ....
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @juliomcrosa: EFECTO DE LA ASPIRINA EN LA SUPERVIVENCIA LIBRE DE DISCAPACIDAD EN ANCIANOS SANOS (¿Cae un mito?) https://t.co/kGh0nJEpLT